InsiderFlow

Richard Scott Struthers

CRNX

Richard Scott Struthers serves as President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

13 trades

$22.41M

Net Position

Net Seller

$22.41M

Companies Traded

1

CRNX

Active Period

Sep 2021 – Sep 2025

13 total trades

Most Recent

Sell CRNX

Sep 26, 2025 · $180.0K

Richard Scott Struthers's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)

Buys

0 · $0.00

Sells

13 · $22.41M

Total Shares Bought

0

Total Shares Sold

687,052

CRNX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Sep 26, 2025Sell4,000$45.00$180.0K0
Mar 19, 2025Sell17,338$34.20$593.0K0
Dec 2, 2024Sell10,000$57.57$575.7K0
May 8, 2024Sell107,448$49.40$5.31M0
Apr 4, 2024Sell40,951$49.17$2.01M0
Mar 18, 2024Sell12,687$38.14$483.9K0
Nov 2, 2023Sell200,000$30.56$6.11M0
Jul 11, 2023Sell50,000$20.21$1.01M0
Jun 16, 2023Sell50,000$20.81$1.04M0
Mar 16, 2023Sell4,628$17.12$79.2K0
Apr 13, 2022Sell138,643$26.83$3.72M0
Apr 5, 2022Sell21,357$25.34$541.2K0
Sep 7, 2021Sell30,000$25.00$750.0K0